NYSE:AVTRAvantor Stock Price, Forecast & News

Avantor's stock was trading at $12.92 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AVTR stock has increased by 44.9% and is now trading at $18.72. View which stocks have been most impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Avantor.

Avantor is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Avantor.

Avantor will be holding an earnings conference call on Wednesday, July 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Avantor Inc (NYSE:AVTR) announced its quarterly earnings results on Wednesday, April, 29th. The company reported $0.17 earnings per share for the quarter, beating analysts' consensus estimates of $0.15 by $0.02. The company earned $1.52 billion during the quarter, compared to the consensus estimate of $1.45 billion. The firm's revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.11 EPS. View Avantor's earnings history.

Avantor issued an update on its second quarter 2020 Pre-Market earnings guidance on Tuesday, July, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.48-1.49 billion, compared to the consensus revenue estimate of $1.44 billion.

11 analysts have issued 1-year target prices for Avantor's shares. Their forecasts range from $15.00 to $23.00. On average, they expect Avantor's share price to reach $18.90 in the next twelve months. This suggests a possible upside of 1.0% from the stock's current price. View analysts' price targets for Avantor.

News stories about AVTR stock have trended somewhat negative recently, according to InfoTrie. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Avantor earned a coverage optimism score of -1.6 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the immediate future. View the latest news about Avantor.

Avantor saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 10,320,000 shares, an increase of 25.1% from the June 15th total of 8,250,000 shares. Based on an average trading volume of 3,630,000 shares, the days-to-cover ratio is presently 2.8 days. Approximately 2.0% of the company's stock are short sold. View Avantor's Current Options Chain.

Some companies that are related to Avantor include Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), Waters (WAT), PerkinElmer (PKI), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and Eyepoint Pharmaceuticals (EYPT). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Eastman Chemical (EMN), Alibaba Group (BABA), Home Depot (HD), Johnson & Johnson (JNJ), Procter & Gamble (PG), AT&T (T), CVS Health (CVS), Honeywell International (HON), Abbott Laboratories (ABT) and Cisco Systems (CSCO).

(AVTR) raised $3 billion in an IPO on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies served as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Avantor trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVTR."

Avantor's stock is owned by many different retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.02%), DNB Asset Management AS (0.01%) and Livforsakringsbolaget Skandia Omsesidigt (0.00%). Company insiders that own Avantor stock include Devashish Ohri, Gerard Brophy, Jo Natauri, Michael Wondrasch and New Mountain Investments Iii,. View institutional ownership trends for Avantor.

AVTR stock was bought by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., DNB Asset Management AS, and Livforsakringsbolaget Skandia Omsesidigt. View insider buying and selling activity for Avantor.

Shares of AVTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AVTR stock can currently be purchased for approximately $18.72.

Avantor has a market capitalization of $10.76 billion and generates $6.04 billion in revenue each year. Avantor employs 12,000 workers across the globe.

The official website for Avantor is www.avantorsciences.com.

Avantor's mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The company can be reached via phone at 610-386-1700 or via email at [email protected]